Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic encephalopathy

K D Mullen1, R Gacad

  • 1Department of Medicine, MetroHealth Medical Center, Case Western Reserve University, School of Medicine, Cleveland, OH, USA.

The Gastroenterologist
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study.

Alimentary pharmacology & therapeutics·2011
Same author

Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.

Alimentary pharmacology & therapeutics·2011
Same author

Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy.

Alimentary pharmacology & therapeutics·2007
Same author

Use of tegaserod along with polyethylene glycol electrolyte solution for colonoscopy bowel preparation: a prospective, randomized, double-blind, placebo-controlled study.

Alimentary pharmacology & therapeutics·2006
Same author

Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review.

Transplant infectious disease : an official journal of the Transplantation Society·2003
Same author

Use of subcutaneous venous access ports to treat refractory ascites.

Journal of vascular and interventional radiology : JVIR·2001
Same journal

Pseudomyxoma peritonei.

The Gastroenterologist·1998
Same journal

Update on obesity treatment.

The Gastroenterologist·1998
Same journal

Pathophysiology and treatment of hepatorenal syndrome.

The Gastroenterologist·1998
Same journal

Common pediatric esophageal disorders.

The Gastroenterologist·1998
Same journal

The technical aspects of biofeedback therapy for defecation disorders.

The Gastroenterologist·1998
Same journal

Magnetic resonance cholangiopancreatography: a new technique for evaluating the biliary tract and pancreatic duct.

The Gastroenterologist·1998
See all related articles

Hepatic encephalopathy (HE) diagnosis and pathogenesis remain challenging. Effective empirical therapies exist, and a new term, acute liver failure-associated hepatic encephalopathy (ALFA-HE), is proposed.

Area of Science:

  • Hepatology
  • Neurology
  • Gastroenterology

Background:

  • Hepatic encephalopathy (HE) has a long history of diagnostic and pathogenic complexity.
  • Existing literature on HE is often confusing and contradictory.
  • Despite challenges, effective empirical therapies for HE have been developed.

Purpose of the Study:

  • To review selected aspects of diagnosis, pathogenesis, clinical manifestations, and treatment of HE.
  • To emphasize a three-pronged clinical strategy for managing HE.
  • To discuss subclinical HE and propose a new term for acute liver failure-associated HE.

Main Methods:

  • Literature review focusing on diagnosis, pathogenesis, clinical manifestations, and treatment of HE.
  • Emphasis on a comprehensive clinical management strategy.

Related Experiment Videos

  • Detailed discussion of subclinical HE and a proposed new nomenclature.

    • Main Results:

    • Effective empirical therapies for HE are available.
    • A structured, three-pronged approach aids in HE management.
    • Subclinical HE is an important area for further investigation.

    Conclusions:

    • Hepatic encephalopathy presents ongoing diagnostic and pathogenic challenges.
    • A strategic, multi-faceted approach is crucial for effective HE management.
    • The proposed term ALFA-HE aims to clarify nomenclature in acute liver failure contexts.